Harvard Bioscience, Inc. (HBIO): Price and Financial Metrics
GET POWR RATINGS... FREE!
HBIO POWR Grades
- Sentiment is the dimension where HBIO ranks best; there it ranks ahead of 95.01% of US stocks.
- HBIO's strongest trending metric is Growth; it's been moving down over the last 179 days.
- HBIO ranks lowest in Momentum; there it ranks in the 38th percentile.
HBIO Stock Summary
- The price/operating cash flow metric for HARVARD BIOSCIENCE INC is higher than 96.87% of stocks in our set with a positive cash flow.
- Over the past twelve months, HBIO has reported earnings growth of -573.64%, putting it ahead of only 3.06% of US stocks in our set.
- Revenue growth over the past 12 months for HARVARD BIOSCIENCE INC comes in at -4.68%, a number that bests only 19.66% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to HARVARD BIOSCIENCE INC are FOXF, MIND, CRSR, CVV, and LFUS.
- Visit HBIO's SEC page to see the company's official filings. To visit the company's web site, go to www.harvardbioscience.com.
HBIO Valuation Summary
- In comparison to the median Healthcare stock, HBIO's price/earnings ratio is 158.85% lower, now standing at -13.3.
- Over the past 243 months, HBIO's price/sales ratio has gone down 1.2.
Below are key valuation metrics over time for HBIO.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
HBIO | 2023-03-17 | 1.1 | 1.8 | -13.3 | -26.6 |
HBIO | 2023-03-16 | 1.0 | 1.6 | -12.4 | -25.2 |
HBIO | 2023-03-15 | 1.0 | 1.5 | -11.7 | -24.3 |
HBIO | 2023-03-14 | 1.0 | 1.6 | -11.8 | -24.5 |
HBIO | 2023-03-13 | 1.0 | 1.5 | -11.3 | -23.8 |
HBIO | 2023-03-10 | 1.0 | 1.6 | -11.8 | -24.5 |
HBIO Growth Metrics
- The 5 year net cashflow from operations growth rate now stands at 61.96%.
- The 2 year net cashflow from operations growth rate now stands at -119.77%.
- The 3 year net income to common stockholders growth rate now stands at -429.23%.

The table below shows HBIO's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 117.963 | -1.41 | -6.889 |
2022-06-30 | 120.704 | -2.719 | -3.654 |
2022-03-31 | 120.693 | -1.761 | -6.499 |
2021-12-31 | 118.904 | 1.262 | -0.288 |
2021-09-30 | 116.833 | 3.635 | -1.864 |
2021-06-30 | 111.207 | 5.892 | -2.792 |
HBIO's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- HBIO has a Quality Grade of C, ranking ahead of 42.11% of graded US stocks.
- HBIO's asset turnover comes in at 0.728 -- ranking 27th of 75 Measuring and Control Equipment stocks.
- CAMT, NVMI, and ITRI are the stocks whose asset turnover ratios are most correlated with HBIO.
The table below shows HBIO's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.728 | 0.566 | -0.002 |
2021-03-31 | 0.693 | 0.574 | 0.005 |
2020-12-31 | 0.666 | 0.568 | -0.027 |
2020-12-31 | 0.666 | 0.568 | -0.027 |
2020-09-30 | 0.657 | 0.564 | -0.018 |
2020-06-30 | 0.665 | 0.560 | -0.029 |
HBIO Price Target
For more insight on analysts targets of HBIO, see our HBIO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $10.00 | Average Broker Recommendation | 1.38 (Strong Buy) |
HBIO Stock Price Chart Interactive Chart >
HBIO Price/Volume Stats
Current price | $3.10 | 52-week high | $6.49 |
Prev. close | $3.18 | 52-week low | $1.98 |
Day low | $3.01 | Volume | 73,770 |
Day high | $3.18 | Avg. volume | 67,791 |
50-day MA | $2.90 | Dividend yield | N/A |
200-day MA | $2.95 | Market Cap | 130.79M |
Harvard Bioscience, Inc. (HBIO) Company Bio
Harvard Bioscience, Inc. develops, manufactures, and markets scientific instruments, systems, and lab consumables used in life science research. The company was founded in 1901 and is based in Holliston, Massachusetts.
Latest HBIO News From Around the Web
Below are the latest news stories about HARVARD BIOSCIENCE INC that investors may wish to consider to help them evaluate HBIO as an investment opportunity.
Sidoti's Small-Cap Virtual March ConferenceSidoti & Company, LLC has released the presentation schedule and weblinks for its two-day March Small-Cap Conference taking place Wednesday and Thursday, March 22-23, 2023. |
Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one meetings with investors at the Sidoti Virtual Investor Conference taking place on March 22-23, 2023. Mr. Green will present on Wednesday, March 22 at 10:00 AM ET. A live webcast of the presentation will be available here. The presentation will also be archived on the Investor Relations section of the Harv |
Harvard Bioscience to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one meetings with investors at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023. Mr. Green will present on Tuesday, March 21 at 9:45 AM ET. A live webcast of the presentation will be available here. The presentation will also be archived on the Investor Relations section of |
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2022 Earnings Call TranscriptHarvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2022 Earnings Call Transcript March 9, 2023 Operator: Good day, and thank you for standing by. Welcome to the Harvard Bioscience Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. Please be advised […] |
Q4 2022 Harvard Bioscience Inc Earnings CallQ4 2022 Harvard Bioscience Inc Earnings Call |
HBIO Price Returns
1-mo | 8.01% |
3-mo | 13.55% |
6-mo | 20.16% |
1-year | -46.55% |
3-year | 58.16% |
5-year | -37.37% |
YTD | 11.91% |
2022 | -60.71% |
2021 | 64.34% |
2020 | 40.66% |
2019 | -4.09% |
2018 | -3.64% |
Continue Researching HBIO
Want to see what other sources are saying about Harvard Bioscience Inc's financials and stock price? Try the links below:Harvard Bioscience Inc (HBIO) Stock Price | Nasdaq
Harvard Bioscience Inc (HBIO) Stock Quote, History and News - Yahoo Finance
Harvard Bioscience Inc (HBIO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...